Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,905 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging.
Azad GK, Taylor BP, Green A, Sandri I, Swampillai A, Harries M, Kristeleit H, Mansi J, Goh V, Cook GJR. Azad GK, et al. Among authors: green a. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):821-830. doi: 10.1007/s00259-018-4223-9. Epub 2018 Dec 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 30506455 Free PMC article. Clinical Trial.
Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.
Westerland O, Amlani A, Kelly-Morland C, Fraczek M, Bailey K, Gleeson M, El-Najjar I, Streetly M, Bassett P, Cook GJR, Goh V; Myeloma Imaging Research Group at Guy’s & St Thomas’ Hospital, London and King’s College London. Westerland O, et al. Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2558-2565. doi: 10.1007/s00259-020-05182-2. Epub 2021 Jan 19. Eur J Nucl Med Mol Imaging. 2021. PMID: 33469686 Free PMC article.
Association of dynamic contrast-enhanced MRI and 18F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer.
Withey SJ, Owczarczyk K, Grzeda MT, Yip C, Deere H, Green M, Maisey N, Davies AR, Cook GJ, Goh V; Guy's & St Thomas' Esophagogastric Research Group. Withey SJ, et al. Eur J Surg Oncol. 2023 Oct;49(10):106934. doi: 10.1016/j.ejso.2023.05.009. Epub 2023 May 10. Eur J Surg Oncol. 2023. PMID: 37183047 Free PMC article.
ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement.
Green S, Tuck S, Long J, Green T, Green A, Ellis P, Haire A, Moss C, Cahill F, McCartan N, Brown L, Santaolalla A, Marsden T, Justo MR, Hadley J, Punwani S, Attard G, Ahmed H, Moore CM, Emberton M, Van Hemelrijck M. Green S, et al. Among authors: green a, green t. Res Involv Engagem. 2021 Nov 17;7(1):81. doi: 10.1186/s40900-021-00322-w. Res Involv Engagem. 2021. PMID: 34789334 Free PMC article.
The Walker-Warburg or a new syndrome?
Baraitser M, Dossetor J, Slaney S, Green A. Baraitser M, et al. Among authors: green a. Acta Ophthalmol Scand Suppl. 1996;(219):8-10. doi: 10.1111/j.1600-0420.1996.tb00372.x. Acta Ophthalmol Scand Suppl. 1996. PMID: 8741105 No abstract available.
6,905 results